In relation to our secondary objective, to examine potential differences in CD8 responses to CBV in patients with T1D compared with non-diabetic controls, we did not observe any differences in the prevalence or breadth of responses. The gene discussed is CD8A; the disease is type 1 diabetes mellitus.